Literature DB >> 9633716

SPECT study of a German CADASIL family: a phenotype with migraine and progressive dementia only.

J K Mellies1, T Bäumer, J A Müller, E Tournier-Lasserve, H Chabriat, O Knobloch, H J Hackelöer, H H Goebel, L Wetzig, P Haller.   

Abstract

OBJECTIVE: We describe the clinical, molecular, genetic, MRI, and SPECT features of a German family with autosomal dominant migraine and dementia, mapping to the cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) locus. We studied the correlation of cerebral blood flow, MRI, and cognitive function.
BACKGROUND: CADASIL is a small-vessel disease of the brain mapped to chromosome 19p13.1. Mutations of the Notch3 gene cause this disorder. Most phenotypes are characterized by transient ischemic attacks (TIAs) and lacunar strokes leading to dementia. Migraine is frequent. A single photon emission computed tomographic (SPECT) study of this disorder has not yet been published.
METHODS: We studied 13 individuals clinically and performed neuroimaging studies with MRI and SPECT.
RESULTS: Genetic analysis strongly supported linkage to the CADASIL locus, and the disease haplotype was found in six individuals. Analysis by single-strand confirmation polymorphism did not identify Notch3 mutations. All affected individuals had MRI white matter hyperintensities and four individuals had additional basal ganglial signal abnormalities. Four affected individuals had migraine, two of whom had slowly progressive dementia. TIAs, stroke, and focal neurologic signs were absent. Cerebral blood flow reduction in SPECT studies of affected individuals matched with MRI signal abnormalities. Cognitive impairment was linked to signal abnormalities and hypoperfusion in the basal ganglia. Demented patients had a pattern of frontal, temporal, and basal ganglial hypoperfusion.
CONCLUSIONS: We describe a CADASIL phenotype that is characterized by the absence of focal neurologic symptoms and present the first SPECT study of this disorder.

Entities:  

Mesh:

Year:  1998        PMID: 9633716     DOI: 10.1212/wnl.50.6.1715

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Adaptive metabolic changes in CADASIL white matter.

Authors:  Tamar Akhvlediani; Anke Henning; Peter S Sándor; Peter Boesiger; Hans H Jung
Journal:  J Neurol       Date:  2009-08-19       Impact factor: 4.849

2.  Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy).

Authors:  Sumeet Singhal; Hugh S Markus
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

3.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance.

Authors:  R Bruening; M Dichgans; C Berchtenbreiter; T Yousry; K C Seelos; R H Wu; M Mayer; G Brix; M Reiser
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

4.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease.

Authors:  Jay Chol Choi
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

5.  Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.

Authors:  Nils Peters; Tobias Freilinger; Christian Opherk; Thomas Pfefferkorn; Martin Dichgans
Journal:  J Neurol       Date:  2008-06-13       Impact factor: 4.849

6.  Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease.

Authors:  Anne Joutel; Marie Monet-Leprêtre; Claudia Gosele; Céline Baron-Menguy; Annette Hammes; Sabine Schmidt; Barbara Lemaire-Carrette; Valérie Domenga; Andreas Schedl; Pierre Lacombe; Norbert Hubner
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

Review 7.  Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?

Authors:  Simona Sacco; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2010-03-12       Impact factor: 7.277

8.  The Siblings With Ischemic Stroke Study (SWISS) protocol.

Authors:  James F Meschia; Robert D Brown; Thomas G Brott; Felix E Chukwudelunzu; John Hardy; Stephen S Rich
Journal:  BMC Med Genet       Date:  2002-02-12       Impact factor: 2.103

9.  Effects of Cerebral Blood Flow and White Matter Integrity on Cognition in CADASIL Patients.

Authors:  Xinzhen Yin; Ying Zhou; Shenqiang Yan; Min Lou
Journal:  Front Psychiatry       Date:  2019-01-14       Impact factor: 4.157

10.  Effects of different regional cerebral blood flow on white matter hyperintensity in CADASIL patients.

Authors:  Runrun Wang; Jiewen Zhang; Junkui Shang; Fengyu Wang; Xi Yan
Journal:  J Biomed Res       Date:  2022-08-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.